2017
DOI: 10.1016/j.ijcard.2017.03.021
|View full text |Cite
|
Sign up to set email alerts
|

Corrigendum to “Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials” [Int. J. Cardiol. (2017) 137–144]

Abstract: Corrigendum to "Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials" [Int. J. Cardiol. (2017) 137-144]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
1
1
0
Order By: Relevance
“…Our study confirmed the result from Kooiman et al that there seemed to be no association between volume of contrast media and CI-AKI [30]. As other studies, use of IOCM showed non-significant benefit in preventing CI-AKI when compared to LOCM in high risk patients [21, 28]. We also found no difference in CI-AKI risk with iodixanol compared with a diverse group of LOCM.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Our study confirmed the result from Kooiman et al that there seemed to be no association between volume of contrast media and CI-AKI [30]. As other studies, use of IOCM showed non-significant benefit in preventing CI-AKI when compared to LOCM in high risk patients [21, 28]. We also found no difference in CI-AKI risk with iodixanol compared with a diverse group of LOCM.…”
Section: Discussionsupporting
confidence: 91%
“…In contrast, other studies demonstrated that there existed no significant difference in CI-AKI incidence (defined by an initial increase in SCr level ≥ 0.5 mg/dl) between IOCM and LOCM in high risk patients [11]. Studies comparing nephrotoxicity of IOCM and LOCM reported a controversial conclusion [2628]. A prior meta-analysis suggested that IOCM had no significant difference in the incidences of post-procedure hemodialysis or death over LOCM [29].…”
Section: Discussionmentioning
confidence: 99%